Factory Supply Diclofenac Sodium Powder - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai
Factory Supply Diclofenac Sodium Powder - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai Detail:
Product name | Rivaroxaban |
Synonyms | 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
CAS No. | 366789-02-8 |
Appearance | White powder |
Molecular Formula | C19H18ClN3O5S |
Molecular Weight | 435.88 |
Application | Pharmaceutical grade or research purpose |
Packing | As per your request |
Storage | Preserve in tight,light-resistant containers in a cool place |
Company Information
√ Management layer’s full experience in factory and skilled technicians followers; √ Quality is always our top consideration, Strict QC system; √ 11 years experienced exporting sales team; √ Independent R&D lab; √ Two signed long term GMP workshops; √ Rich resources of plenty idle factories for customized project; √ High Efficiency working team with consistent path.Product detail pictures:
Related Product Guide:
Our advancement depends over the superior machines, exceptional talents and continually strengthened technology forces for Factory Supply Diclofenac Sodium Powder - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai , The product will supply to all over the world, such as: US, Serbia, Mexico, As an experienced factory we also accept customized order and make it same as your picture or sample specifying specification and customer design packing. The main goal of the company is to live a satisfactory memory to all the customers,and establish a long term win-win business relationship. For more information,please contact us. And it's our great pleasure if you like to have a personally meeting in our office.
By Andrea from Melbourne - 2018.10.01 14:14
We are long-term partners, there is no disappointment every time, we hope to maintain this friendship later!
By Katherine from Islamabad - 2018.09.29 13:24
Write your message here and send it to us